Back to Search
CASEY SUMNER, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1245830934Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
2006031388(MO)17604(AL)
Research & Publications (20)
Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice.
PMID 19477958·Hum Mol Genet·2009
7-preclinical
Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.
PMID 19318988·J Am Acad Child Adolesc Psychiatry·2009
8-other
Factors affecting the selectivity of the oxidation of methyl p-toluate by cobalt(III).
PMID 18225893·Inorg Chem·2008
8-other
Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.
PMID 17712235·J Am Acad Child Adolesc Psychiatry·2007
2-rct
Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis.
PMID 17201614·J Child Adolesc Psychopharmacol·2006
2-rct
SMN mRNA and protein levels in peripheral blood: biomarkers for SMA clinical trials.
PMID 16481599·Neurology·2006
8-other
Valproic acid increases SMN levels in spinal muscular atrophy patient cells.
PMID 14595654·Ann Neurol·2003
4-observational
The spectrum of neuropathy in diabetes and impaired glucose tolerance.
PMID 12525727·Neurology·2003
3-trial
A nonlinear filter-bank model of the guinea-pig cochlear nerve: rate responses.
PMID 12822799·J Acoust Soc Am·2003
7-preclinical
Recurrent myelopathy after HAART in a patient with spinal mycobacterial infection.
PMID 12847179·Neurology·2003
5-case
Should thrombolysis be contraindicated in patients with cerebral arteriovenous malformations?
PMID 12394968·Crit Care Med·2002
5-case
A revised model of the inner-hair cell and auditory-nerve complex.
PMID 12051437·J Acoust Soc Am·2002
8-other
Emerging treatment options for spinal muscular atrophy.
PMID 19210911·Curr Treat Options Neurol·2009
8-other
Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing.
PMID 19420182·Clin Pediatr (Phila)·2009
4-observational
Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy.
PMID 19679072·Neuron·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1930 PLEASANT RIDGE LOOP
SYLACAUGA, AL 35150 - Phone
- (417) 536-1823
Quick Facts
- NPI
- 1245830934
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile